3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
4
Stomach Neoplasms
2
Esophageal Neoplasms
2
Squamous-Cell Lung Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Liver Neoplasms
1
Gallbladder Neoplasms
1
Fallopian Tube Neoplasms
1
Colonic Neoplasms
1
Biliary Tract Neoplasms
1
Adenocarcinoma of Lung
1
Interventions
Oxaliplatin
4
Gemcitabine
4
Fluorouracil
3
Capecitabine
3
Tegafur
2
Stents
2
Radiofrequency Ablation
2
Leucovorin
2
Irinotecan
2
toripalimab
1
tislelizumab
1
taxane
1
surufatinib
1
lenvatinib
1
apixaban
1
apatinib
1
aldesleukin
1
Urination
1
Trastuzumab
1
Tomography, X-Ray Computed
1
Temozolomide
1
Taxes
1
Standard of Care
1
Sorafenib
1
S 1 (combination)
1
Rivaroxaban
1
Radiotherapy
1
Polymerase Chain Reaction
1
Platinum Compounds
1
Observation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Gallbladder Neoplasms
×
Platinum Compounds
×
Clear all
NCT03668418
2018-09-12
xenoZ
University of Pisa
Unknown
120 enrolled